Evidence map›Paper›PMID 34171504›Full record

ArticleComputational biology and chemistry2021

A computational analysis of molecular evolution for virulence genes of zoonotic novel coronavirus (COVID-19).

Priya Kumari, Raju Poddar

Abstract read
In one paragraph

Article in Computational biology and chemistry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Priya KumariDepartment of Bioengineering, Birla Institute of Technology-Mesra, Ranchi, JH 835 215, India.
Raju PoddarDepartment of Bioengineering, Birla Institute of Technology-Mesra, Ranchi, JH 835 215, India. Electronic address: rpoddar@bitmesra.ac.in.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Zoonotic Novel coronavirus disease 2019 (COVID-19) is highly pathogenic and transmissible considered as emerging pandemic disease. The virus belongs from a large virus Coronaviridae family affect respiratory tract of animal and human likely originated from bat and homology to SARA-CoV and MERS-CoV. The virus consists of single-stranded positive genomic RNA coated by nucleocapsid protein. The rate of mutation in any virulence gene may influence the phenomenon of host radiation. We have studied the molecular evolution of selected virulence genes (HA, N, RdRP and S) of novel COVID-19. We used a site-specific comparison of synonymous (silent) and non-synonymous (amino acid altering) nucleotide substitutions. Maximum Likelihood genealogies based on differential gamma distribution rates were used for the analysis of null and alternate hypothesis. The null hypothesis was found more suitable for the analysis using Likelihood Ratio Test (LRT) method, confirming higher rate of substitution. The analysis revealed that RdRP gene had the fastest rate evolution followed by HA gene. We have also reported the new motifs for different virulence genes, which are further useful to design new detection and diagnosis kit for COVID -19.

Indexed as

Amino Acid SubstitutionBase SequenceCoronavirus Nucleocapsid ProteinsCoronavirus RNA-Dependent RNA PolymeraseEvolution, MolecularGenes, ViralHemagglutininsPhosphoproteinsSARS-CoV-2Spike Glycoprotein, CoronavirusVirulenceCoronavirus Nucleocapsid ProteinsCoronavirus RNA-Dependent RNA PolymeraseHemagglutininsnucleocapsid phosphoprotein, SARS-CoV-2PhosphoproteinsSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2Adaptive molecular evolutionCOVID-19HemagglutininLikelihood ratio testMarkov modelPositive selectionRdRPZoonotic

Identifiers

PMID34171504
PMCPMC8213524

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.